Cargando…

Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose

Detalles Bibliográficos
Autores principales:	Attolico, Immacolata, Tarantini, Francesco, Carluccio, Paola, Musto, Pellegrino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052926/ https://www.ncbi.nlm.nih.gov/pubmed/35045696 http://dx.doi.org/10.3324/haematol.2022.280619

Ejemplares similares

Serological Response Following BNT162b2 Anti-Sars-Cov-2 mRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients
por: Attolico, Imma, et al.
Publicado: (2021)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

P1319: T AND B LYMPHOCYTES SUBSETS AFTER BNT162B2 ANTI-SARS-COV-2 M-RNA VACCINATION: A COMPARISON BETWEEN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS AND HEALTHY CONTROLS.
por: Attolico, I., et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Neutropenic diets in hematopoietic stem cell transplantation
por: Albertini, Silvia Maria
Publicado: (2012)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Importance of functional evaluation after hematopoietic cell transplantation
por: Flowers, Mary Evelyn Dantas
Publicado: (2012)

Body composition assessment in hematopoietic stem cell transplantation()
por: Ueda, Masumi
Publicado: (2017)

Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation()
por: Macedo, Antonio Vaz de
Publicado: (2020)

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
por: Heimbach, Julie K, et al.
Publicado: (2020)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

COVID-19 and liver transplantation
por: Di Maira, Tommaso, et al.
Publicado: (2020)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms
por: Caza, Tiffany N, et al.
Publicado: (2023)

Testing the functional reserve of the kidney before hematopoietic stem cell transplantation: doubt remains
por: De Moor, Bart, et al.
Publicado: (2023)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

The impact of COVID-19 on kidney transplantation
por: Alasfar, Sami, et al.
Publicado: (2020)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Vitamin D binding protein and endothelial injury after hematopoietic stem cell transplantation: an actin scavenger with a lipid-bound character
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Clostridium difficile infection is a frequent but well-controlled event after hematopoietic cell transplantation()
por: Caimi, Paolo Fabrizio
Publicado: (2015)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

Population serology for SARS-CoV-2 is essential to regional and global preparedness
por: Tian, Huaiyu, et al.
Publicado: (2020)

When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

Physically “fit” for allogeneic stem cell transplant?
por: Jayani, Reena V., et al.
Publicado: (2021)

Induction Treatment in Transplant-eligible Multiple Myeloma
por: Quinn, J., et al.
Publicado: (2021)

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
por: Khawaja, Fareed, et al.
Publicado: (2022)

Comment on: clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation
por: Daudt, Liane Esteves
Publicado: (2012)

Comment on “Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study”()
por: Schmidt, Erin M., et al.
Publicado: (2014)

Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study
por: Banjongjit, Athiphat, et al.
Publicado: (2022)

Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
por: De Luca, Luciana, et al.
Publicado: (2017)

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)

Targeting the microbiome: from probiotics to fecal microbiota transplantation
por: Khoruts, Alexander
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_enftrcvs52jr14oovj74gi1kth